Pfizer CEO: Tariff Threats Could Lead to Overseas Manufacturing Shift

Generado por agente de IAMarcus Lee
martes, 4 de marzo de 2025, 2:29 am ET1 min de lectura
CWEN--
PFE--
TD--

Pfizer CEO Albert Bourla has hinted that the company may shift some of its overseas manufacturing to the United States in response to potential tariff threats from the Trump administration. Speaking at TDTD-- Cowen's 45th annual healthcare conference in Boston, Bourla acknowledged the uncertainty surrounding potential tariffs on pharmaceutical imports and suggested that PfizerPFE-- is well-positioned to adapt to any changes.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios